The main mechanism of HER2 activation in human breast and gastric cancers is HER2 gene amplification, leading to overexpression of its protein on the cell membrane, which is associated with disease recurrence and short overall patient survival [76,77]. Here, ERBB2 is linked to gastric cancer.